FDA grants Infant Bacterial Therapeutics Type B pre-BLA meeting request
FDA granted Infant Bacterial Therapeutics AB’s request for a Type B pre-BLA meeting to discuss its BLA preparation. The meeting is scheduled for October 29, 2026, in Washington.
FDA granted Infant Bacterial Therapeutics AB’s request for a Type B pre-BLA meeting to discuss its BLA preparation. The meeting is scheduled for October 29, 2026, in Washington.